Industry NewsAccess human allograft tissue and regenerative medicine industry news.
Mikos lab aids new push for regenerative medicine
Rice University bioengineers led by Antonios Mikos will take part in a five-year, $20 million effort to apply advanced manufacturing techniques to regenerative medicine.
The goal of the effort led by the Wake Forest Institute for Regenerative Medicine is to speed up the availability of replacement tissue and organs to patients.Read More
This is Not a Test: RMAT Designation Goes Live
The field of regenerative medicine encompasses a wide scope of innovative products including cell therapies, therapeutic tissue engineering products, human cell and tissue products, and certain combination products using such therapies. Examples include genetically-modified cellular therapies, such as chimeric antigen receptor T-cells (CAR-T cells) and human tissues grown on scaffolds for subsequent use. These products hold great promise in addressing serious unmet medical needs. For example, data from a number of different published studies indicate the potential for CAR-T cells to treat certain relapsed or refractory blood cancers.Read More
Regenerative medicine is likely game changer for cardiovascular disease
Regenerative medicine has much to offer the cardiovascular field, although there is still a way to go before it is ready for routine clinical application, according to Andre Terzic, MD, PhD, director of the Mayo Clinic Center for Regenerative Medicine and a professor in Cardiovascular Diseases Research at the Mayo Clinic, in Rochester, Minn.Read More
Application of Amniotic Tissue in Orthopedic Surgery
The use of amniotic tissue in orthopedic surgery has increased in recent years. While more studies are needed to fully understand the therapeutic potential and define the appropriate applications of these tissues, basic science and clinical studies are available that indicate promising results. This review will highlight these studies as they relate to the musculoskeletal system.Read More
Demineralized Allografts Market grows with rapidly aging population and increasing obesity rates
Bone grafts are generally utilized for bone regeneration, pain relief and structure restoration for decades all over the world. Conservatively, autografts were used for bone grafting, in which patient’s own bone was used as a graft. Autologous bone grafts have proven very useful and is recognized as a gold standard for bone transplant. On the contrary, use of autologous bone grafts embraces the risk of infection transfer. This infection transfer during surgical procedures at both tissue harvesting and transplant sites results in late wound healing and prolonged hospital stay. Therefore, allografts were introduced in the market for overcoming the disadvantages associated with autologous grafts. Allografts possess both osteoinductive and osteoconductive properties, and hence serve as a worthy substitute for autografts.Read More
The Highs and Lows of Regenerative Medicine
Nanoscale manipulation on the surface of materials could stimulate cells to differentiate into specific tissues – eliminating the use of growth or transcription factors.Read More
Researchers are trying to find ways to control cellular response in vitro using engineered materials in a continuous pursuit to regenerate injured or diseased tissues. Recent studies have found that nanoscale structure of the materials, on which such cells are cultured, affect how well they proliferate and develop into the tissues they are meant to become.
The Knotty Problem of Bringing Regenerative Medicine to Market
When Lawrence Summers delivered his last commencement address as Harvard’s president 10 years ago, he spoke of the rosy future for stem cell science and regenerative medicine.Read More
The advancing technology, he said then, promised a cure for cancer, another for diabetes, a vaccine for Alzheimer’s disease, and ways to control AIDS, any one of which would have enormous impact around the world. Today, he believes he was too pessimistic.
Researchers Solve Mystery on How Regenerative Medicine Works
A study from the University of Pittsburgh School of Medicine and the McGowan Institute for Regenerative Medicine identifies a mechanism by which bioscaffolds used in regenerative medicine influence cellular behavior, a question that has remained unanswered since the technology was first developed several decades ago. The findings were recently published online in Science Advances.Read More
Recent progress in tracking the viability of transplanted stem cells in vivo
Noninvasive cell-tracking methods are indispensable for assessing the safety and efficacy of stem-cell based therapy. Thus, the research of noninvasive cell-tracking methods for determining in vivo the translocation and long-term viability of the transplanted stem cells have received considerable attention. A recent review article summarized the recent progress in tracking the viability of the transplanted stem cells in vivo. Source: Science China PressRead More
New FDA draft guidelines place tighter restrictions on surgical practices using tissue-based regenerative therapies
The therapeutic use of human cell and tissue products is highly regulated by the U.S. government, but a specific exception allows surgeons to harvest, manipulate, and implant tissues in many commonly performed procedures. Source: News MedicalRead More